you are here:

Jubilant Pharmova Ltd.

BSE: 530019 | NSE: JUBLPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE700A01033 | SECTOR: Pharmaceuticals

BSE Live

Oct 27, 16:00
600.15 -1.00 (-0.17%)
Volume
AVERAGE VOLUME
5-Day
23,921
10-Day
22,643
30-Day
19,578
14,827
  • Prev. Close

    601.15

  • Open Price

    602.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 27, 15:57
600.60 -0.05 (-0.01%)
Volume
AVERAGE VOLUME
5-Day
277,438
10-Day
264,939
30-Day
243,481
98,209
  • Prev. Close

    600.65

  • Open Price

    605.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    600.60 (20)

ANNOUNCEMENTS ON Jubilant Pharmo

  • Oct 25, 2021 11:40 Source: NSE

    Jubilant Pharmova Limited

    Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication

  • Oct 19, 2021 15:17 Source: BSE

    Jubilant Pharmova - Shareholding for the Period Ended September 30, 2021

    Jubilant Pharmova Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here

  • Oct 14, 2021 18:34 Source: BSE

    Jubilant Pharmova - Schedule Of Investor Conference Call For Jubilant Pharmova Limited - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021

    Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on October 22, 2021 after submission of the financial results for the quarter and half year ended September 30, 2021 to the Stock Exchanges. Details of the Conference Call are attached.

  • Oct 14, 2021 18:23 Source: BSE

    Jubilant Pharmova - Board Meeting Intimation for Intimation Of Board Meeting - October 22, 2021

    Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 22, 2021, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2021.

  • Oct 12, 2021 17:37 Source: BSE

    Jubilant Pharmova - Statement Of Investor Complaints For The Quarter Ended September 2021

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0110
    Name of the Signatory :- Rajiv Shah
    Designation :- Company Secretary and Compliance Officer

  • Oct 12, 2021 17:11 Source: BSE

    Jubilant Pharmova - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

  • Sep 29, 2021 17:21 Source: BSE

    Jubilant Pharmova - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has issued duplicate share certificate to the member as per the attachment. This is for your information and record.

  • Sep 24, 2021 20:04 Source: BSE

    Jubilant Pharmova - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

    Jubilant Pharmova Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

  • Sep 23, 2021 19:57 Source: BSE

    Jubilant Pharmova - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

    This is further to our letter dated September 22, 2021. Pursuant to the provisions of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Details of the voting results in respect of the 43rd Annual General Meeting of the shareholders of the Company held on Wednesday, September 22, 2021 through Video Conferencing/ Other Audio Visual Means as Annexure 1. 2. Consolidated Scrutinizer''s Report pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 as Annexure 2. We request you to take the same on records.

  • Sep 23, 2021 17:38 Source: BSE

    Jubilant Pharmova - Closure of Trading Window

    Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Friday, September 24, 2021 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter ending September 30, 2021 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and records.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Oct 22, 2021
Remark : Quarterly Results